| |
| |
|
| Insider
Information: |
Lyons Gary A |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
581,453 |
|
|
Indirect Shares
|
387,931 |
|
|
| Direct
Value |
$26,913,457 |
|
|
|
Indirect Value
|
$52,435,561 |
|
|
| Total
Shares |
969,384 |
|
|
| Total
Value |
$79,349,018 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Director |
2023-12-22 |
193,697 |
2005-12-19 |
383,573 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2003-11-25 |
0 |
2003-11-25 |
0 |
Premium* |
|
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
Director |
2020-12-31 |
18,762 |
2009-05-21 |
0 |
Premium* |
|
|
Poniard Pharmaceuticals |
PARD |
Director |
2011-07-11 |
206,145 |
2010-07-12 |
0 |
Premium* |
|
|
Plus Therapeutics Inc |
PSTV |
Director |
2015-05-08 |
36,849 |
2016-06-15 |
4,358 |
Premium* |
|
|
Travere Therapeutics, Inc |
TVTX |
|
2024-05-08 |
51,000 |
2014-10-08 |
0 |
Premium* |
|
|
Rigel Pharmaceuticals Inc |
RIGL |
|
2023-05-26 |
75,000 |
2021-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
111 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2004-03-01 |
4 |
A |
$55.15 |
$220,600 |
D/D |
4,000 |
676,013 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2004-12-08 |
4 |
A |
$45.87 |
$298,155 |
I/I |
6,500 |
626,723 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2005-02-14 |
4 |
A |
$42.78 |
$241,493 |
D/D |
5,645 |
632,368 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
officerTitle |
• • – |
2005-12-19 |
4 |
A |
$61.39 |
$346,669 |
I/I |
5,647 |
383,573 |
|
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Director |
– • – |
2009-05-21 |
4 |
A |
$0.01 |
$125 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2013-10-07 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
21,000 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2014-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,409 |
24,409 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Director |
– • – |
2014-05-22 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
70,781 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2014-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,440 |
12,440 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
78,281 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2015-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
22,000 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2016-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
24,000 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
26,500 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2018-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
29,000 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2019-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
31,000 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
34,000 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Director |
– • – |
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
17,261 |
20,389 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Director |
– • – |
2020-09-15 |
4 |
A |
$0.81 |
$9,667 |
D/D |
11,934 |
24,729 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
37,000 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
40,000 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
50,000 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
44,500 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
75,000 |
0 |
- |
|
111 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
